e-therapeutics plc Stock London S.E.
Equities
ETX
GB00B2823H99
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9 GBX | -6.74% | -.--% | +9.22% |
Sales 2023 | 475K 604K | Sales 2024 | 318K 405K | Capitalization | 95.46M 121M |
---|---|---|---|---|---|
Net income 2023 | -8M -10.18M | Net income 2024 | -11M -13.99M | EV / Sales 2023 | 186 x |
Net cash position 2023 | 31.39M 39.94M | Net cash position 2024 | 19.96M 25.38M | EV / Sales 2024 | 237 x |
P/E ratio 2023 |
-13.3
x | P/E ratio 2024 |
-8.55
x | Employees | 34 |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 29.94% |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ETXPF Stock
- ETX Stock